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PK 506 is a recently discovered immunosuppressive 
macrolide I that has been shown to be significantly 
more potent than cyciosporine A (CyA) in a variety of in 
vitro and in vivo assaysK~-s Like CyA. FK 506 inhibits the 
transcription of early T-cell activation genes6 following 
binding to a cytoplasmic receptor FK-binding protein 
(FKBP).7-9 
It has recently been demonstrated that transforming 
growth factor beta (TGF-,B) has the ability to regulate 
immune functions in vitro,lo.11 and has therefore been 
used as an immunosuppressant in cardiac and islet allo-
transplantation. 12-14 It is interesting to speculate that one 
of the pathways by which immunosuppressants like FK 
506 may act is by inducing endogenous TGF-,B expression. 
MATERIALS AND METHODS 
A rat liver transplant model was used to study the effect of FK 506 
administration on FKBP and TGF-/3 gene expression. Livers 
harvested from ACI donors were onhotopically transplanted in 
Lewis recipients. 15 Following onhotopic liver transplantation 
(OLTX), recipients were either treated with 1.28 mg/kg body 
weight of intramuscular FK 506 for 4 days (n == 15) or left 
untreated (control, n = 12). Three animals each were killed on 
postoperative days 3, 6, and 9 in the control group and on days 3, 
6,9. and 12 in the FK 506-treated group. Total cellular RNA was 
extracted and purified by the method of Chomczynski and Sac-
chi.16 For Nonhern analysis, RNA samples were fractionated on 
0.7% agarose. 18% formaldehyde gels and transferred to nitrocel-
lulose paper. Hybridization was carried out at 60°C overnight in 
Church buffer" and a 32P-Iabeled complementary DNA probe. 
The filters were washed twice for 20 minutes at room temperature in 
1 x SSC (SSC = ISO mmolfL sodium chloride. 15 mmollL sodium 
citrate. pH 7). 0.1% sodium dodecyl sulfate and 0.1 SSC, 0.1% 
sodium dodecyl sulfate at 65"C. The filter was exposed to Kodak 
X-omat film for 4 days with an intensifying screen at -7O"C. 
RESULTS 
Fig 1 depicts the autoradiographs for FKBP expression. 
FKBP gene expression was observed in both untreated 
control. and FK 506-treated recipients on all the days 
studied. 
Fig 2 is the autoradiographs for TGF-,B expression. No 
evidence of TGF-,B gene expression was observed in 
untreated control livers. On the other hand. FK 506-
treated livers showed an induction of TGF-,B gene expres-
sion on days 3 and 6, which tapered off on days 9 and 12 
following orthotopic transplantation. 
DISCUSSION 
Our results demonstrated no association between treat-
ment with FK 506 and FKBP gene expression. Both FKBP 
Fig 1. Autoradiograph for FKBP expression. FKBP gene expres-
sion was observed in both control (lanes 2-4) and FK 506-treated 
recipients (lanes 5--8) on all the days studied. 
and its cyciosporine binding counterpart cyciophilin are 
ubiquitous immunophilins with rotamase activity.18.19 It 
has recently been reported that inhibition of the rotamase 
activity of FKB following FK 506 binding cannot explain 
the biologic effects of FK 506 administration. 18 This would 
appear to confirm the lack of correlation between FK 506 
treatment and FKBP expression observed in our study. 
TGF-f3 gene expression was observed as early as the 
third postoperative day and persisted on the sixth postop-
erative day, tapering off on days 9 and 12. No evidence of 
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Fig 2. Autoradiograph for qdc-~ expression. No evidence of 
TGF-13 gene expression was observed in control livers (lanes 1-3). 
On the other hand, FK 506-treated livers showed an induction of 
TGF-13 gene expression on days 3 and 6 (lanes 4 and 5), which 
tapered off on days 9 and 12 (lanes 6 and 7) following OL Tx. 
TGF-f3 gene expression was noted in untreated control 
livers. The immunoregulatory properties ofTGF-f3 include 
inhibition of cytokine production,20 cytotoxic T-cell gen-
eration,21 thymocyte proliferation,22 and T celllB cell 
generation.23 It has been successfully used to prevent 
allorejection in murine cardiac and islet transplanta-
tion l 2-IS and in murine models of autoimmune disease,z4.25 
It is therefore interesting to speculate that FK 506 may be 
exerting its immunosuppressant action through the induc-
tion of TGF-f3. 
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